User contributions for Cassandra Abueg

30 November 2010

• 19:1819:18, 30 November 2010 diff hist −514 m Template:Acne Agents Reverted edits by Corwin451990 (Talk) to last version by C Michael Gibson
• 19:1719:17, 30 November 2010 diff hist −2,782 m Template:Chemotherapeutic agents Reverted edits by Leo583510 (Talk) to last version by Zorkun current
• 19:1019:10, 30 November 2010 diff hist −1,152 m Template:Antivirals Reverted edits by Percy431868 (Talk) to last version by C Michael Gibson
• 18:5918:59, 30 November 2010 diff hist −797 m Template:Antibiotics and chemotherapeutics for dermatological use Reverted edits by Keegan905946 (Talk) to last version by LBiller current
• 18:4918:49, 30 November 2010 diff hist −546 m Template:Antimycobacterials Reverted edits by Willard565293 (Talk) to last version by C Michael Gibson
• 18:4118:41, 30 November 2010 diff hist −62 m Minocycline Oral (patient information) Reverted edits by Gavin403605 (Talk) to last version by Jackbot
• 18:3818:38, 30 November 2010 diff hist −55 m Diclofenac ophthalmic (patient information) Reverted edits by Charles973805 (Talk) to last version by Jackbot

22 November 2010

• 16:0216:02, 22 November 2010 diff hist −16 Nuclear medicine No edit summary
• 15:5915:59, 22 November 2010 diff hist −19 Nuclear medicine No edit summary
• 15:5115:51, 22 November 2010 diff hist +13,180 Nuclear medicine No edit summary

19 November 2010

• 17:5617:56, 19 November 2010 diff hist +26 A comparison of the RE-LY and Rocket AF Trials No edit summary
• 17:5017:50, 19 November 2010 diff hist +1 A comparison of the RE-LY and Rocket AF Trials →Statistical Methods: Efficacy
• 17:4817:48, 19 November 2010 diff hist +264 A comparison of the RE-LY and Rocket AF Trials →Comparison of RE-LY and Rocket AF Trials
• 17:2817:28, 19 November 2010 diff hist +6,092 A comparison of the RE-LY and Rocket AF Trials No edit summary

18 November 2010

• 21:4321:43, 18 November 2010 diff hist −1 Dabigatran →Rates of Drug Discontinuation
• 21:3821:38, 18 November 2010 diff hist +2,320 Dabigatran →Rocket AF was a Higher Risk Patient Population
• 21:1021:10, 18 November 2010 diff hist +589 Dabigatran →Rocket AF: Baseline Demographics
• 21:0021:00, 18 November 2010 diff hist +588 Dabigatran →RE-LY: Baseline Characteristics
• 20:4320:43, 18 November 2010 diff hist +511 Dabigatran →RE-LY: Baseline Characteristics
• 20:2420:24, 18 November 2010 diff hist +232 Dabigatran →Rates of Drug Discontinuation
• 20:1120:11, 18 November 2010 diff hist +425 Dabigatran →Statistical Methods
• 19:4519:45, 18 November 2010 diff hist +174 Dabigatran →Trial Execution
• 19:2919:29, 18 November 2010 diff hist −4 Dabigatran →Statistical Methods
• 19:2519:25, 18 November 2010 diff hist +8 Dabigatran →Statistical Methods
• 19:2219:22, 18 November 2010 diff hist +164 Dabigatran →Trial Execution
• 18:4918:49, 18 November 2010 diff hist +140 Dabigatran →Statistical Methods
• 18:4018:40, 18 November 2010 diff hist +384 Dabigatran →Comparison of RE-LY and Rocket AF Trials
• 18:3618:36, 18 November 2010 diff hist −166 Dabigatran →Comparison of RE-LY and Rocket AF Trials